Genetic evidence suggests that shared pathways exist between depression and insulin-related diseases, such as metabolic syndrome and type 2 diabetes, with insulin resistance potentially serving as a metabolic subtype of depression and offering a target for personalized treatments [114]. The gene discussed is INS; the disease is depressive symptom measurement.